Market Cap 9.15B
Revenue (ttm) 12.82B
Net Income (ttm) 936.34M
EPS (ttm) N/A
PE Ratio 13.20
Forward PE 11.81
Profit Margin 7.31%
Debt to Equity Ratio -95.97
Volume 699,200
Avg Vol 718,582
Day's Range N/A - N/A
Shares Out 71.50M
Stochastic %K 83%
Beta 1.13
Analysts Sell
Price Target $150.86

Company Profile

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative se...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 720-631-2100
Address:
2000 16th Street, Denver, United States
Noname2022
Noname2022 Oct. 25 at 12:07 AM
$DVA Available almost everywhere *** NOT at DAVITA ***
0 · Reply
Noname2022
Noname2022 Oct. 24 at 10:07 AM
$DVA DVA: Deadly Vascular Access or DefenCath Value Added
0 · Reply
Noname2022
Noname2022 Oct. 23 at 8:57 PM
$CRMD $DVA Why promote, DVA contract?!
1 · Reply
Noname2022
Noname2022 Oct. 23 at 8:40 PM
$CRMD $DVA DVA: Deadly Vascular Access or DefenCath Value Added
0 · Reply
RyGuy_79
RyGuy_79 Oct. 23 at 3:14 PM
$CRMD $DVA uses dog water in their catheter locks.
0 · Reply
Noname2022
Noname2022 Oct. 22 at 2:46 PM
$CRMD $DVA $FMS While every other provider protects patients, DaVita chooses to ignore DefenCath, the therapy proven to prevent deadly infections and costly hospitalizations. This isn’t caution or strategy, it’s negligence dressed as cost control. The market sees it, regulators see it, and patients feel it. When the fallout hits, it won’t be measured in dollars, it will be measured in lives.
5 · Reply
SuperGreenToday
SuperGreenToday Oct. 21 at 11:26 PM
$DVA Share Price: $128.40 Contract Selected: Mar 20, 2026 $130 Calls Buy Zone: $9.43 – $11.65 Target Zone: $17.50 – $21.39 Potential Upside: 75% ROI Time to Expiration: 149 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
WARRENBUFFETSIGNAL
WARRENBUFFETSIGNAL Oct. 20 at 8:58 PM
0 · Reply
SweStonk
SweStonk Oct. 20 at 7:41 PM
$CRMD Great day today! $10,99 entry start to feel good after I sold on the runup with a 240% gain 🤑 Hope we start kicking our ATH soon. Sector seems healthy and getting attention which might give us some extra push this time. I hope we hit $22-$24 until next big pullback and then climb our way to $30 🤞 Defencath once again carry us through the crap. Time for $DVA to step up and provide the best care for their patients which is defencath.
0 · Reply
Noname2022
Noname2022 Oct. 18 at 6:05 PM
3 · Reply
Latest News on DVA
DaVita Inc. Schedules 3rd Quarter 2025 Investor Conference Call

Oct 13, 2025, 2:00 PM EDT - 12 days ago

DaVita Inc. Schedules 3rd Quarter 2025 Investor Conference Call


DaVita: Aggressive Buybacks Despite Rising Cost Of Debt

Aug 20, 2025, 9:36 AM EDT - 2 months ago

DaVita: Aggressive Buybacks Despite Rising Cost Of Debt


DaVita Inc. (DVA) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 10:02 PM EDT - 2 months ago

DaVita Inc. (DVA) Q2 2025 Earnings Call Transcript


DaVita Inc. 2nd Quarter 2025 Results

Aug 5, 2025, 4:05 PM EDT - 2 months ago

DaVita Inc. 2nd Quarter 2025 Results


DaVita Inc. Schedules 2nd Quarter 2025 Investor Conference Call

Jul 17, 2025, 5:37 PM EDT - 3 months ago

DaVita Inc. Schedules 2nd Quarter 2025 Investor Conference Call


DaVita: International Expansion And Buybacks Will Boost Returns

May 27, 2025, 11:30 AM EDT - 5 months ago

DaVita: International Expansion And Buybacks Will Boost Returns


DaVita Inc. Announces Offering of $750 Million Senior Notes

May 20, 2025, 8:51 AM EDT - 5 months ago

DaVita Inc. Announces Offering of $750 Million Senior Notes


DaVita Inc. (DVA) Q1 2025 Earnings Call Transcript

May 12, 2025, 9:41 PM EDT - 5 months ago

DaVita Inc. (DVA) Q1 2025 Earnings Call Transcript


DaVita First-Quarter 2025 Financial Results: Just the Numbers

May 12, 2025, 4:51 PM EDT - 5 months ago

DaVita First-Quarter 2025 Financial Results: Just the Numbers


DaVita Inc. 1st Quarter 2025 Results

May 12, 2025, 4:05 PM EDT - 5 months ago

DaVita Inc. 1st Quarter 2025 Results


DaVita Inc. Schedules 1st Quarter 2025 Investor Conference Call

Apr 30, 2025, 11:00 AM EDT - 6 months ago

DaVita Inc. Schedules 1st Quarter 2025 Investor Conference Call


DaVita Says Ransomware Attack Affecting Some Operations

Apr 14, 2025, 7:35 AM EDT - 6 months ago

DaVita Says Ransomware Attack Affecting Some Operations


Dialysis firm DaVita hit by ransomware attack

Apr 14, 2025, 7:33 AM EDT - 6 months ago

Dialysis firm DaVita hit by ransomware attack


Berkshire Hathaway sells another 750,000 DaVita shares

Feb 19, 2025, 8:05 PM EST - 8 months ago

Berkshire Hathaway sells another 750,000 DaVita shares


DaVita Inc. (DVA) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 8:19 PM EST - 9 months ago

DaVita Inc. (DVA) Q4 2024 Earnings Call Transcript


Berkshire sells some DaVita shares, cuts stake to 45%

Feb 13, 2025, 8:13 PM EST - 9 months ago

Berkshire sells some DaVita shares, cuts stake to 45%


DaVita forecasts 2025 profit below estimates, shares plummet

Feb 13, 2025, 6:07 PM EST - 9 months ago

DaVita forecasts 2025 profit below estimates, shares plummet


DaVita Inc. 4th Quarter 2024 Results

Feb 13, 2025, 4:05 PM EST - 9 months ago

DaVita Inc. 4th Quarter 2024 Results


DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call

Jan 30, 2025, 11:55 AM EST - 9 months ago

DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call


DaVita Inc. (DVA) Q3 2024 Earnings Call Transcript

Oct 29, 2024, 9:27 PM EDT - 1 year ago

DaVita Inc. (DVA) Q3 2024 Earnings Call Transcript


DaVita misses third-quarter profit estimates on higher costs

Oct 29, 2024, 4:23 PM EDT - 1 year ago

DaVita misses third-quarter profit estimates on higher costs


DaVita Inc. 3rd Quarter 2024 Results

Oct 29, 2024, 4:05 PM EDT - 1 year ago

DaVita Inc. 3rd Quarter 2024 Results


DaVita Appoints Jessica Hergenreter as Chief People Officer

Oct 17, 2024, 1:00 PM EDT - 1 year ago

DaVita Appoints Jessica Hergenreter as Chief People Officer


Noname2022
Noname2022 Oct. 25 at 12:07 AM
$DVA Available almost everywhere *** NOT at DAVITA ***
0 · Reply
Noname2022
Noname2022 Oct. 24 at 10:07 AM
$DVA DVA: Deadly Vascular Access or DefenCath Value Added
0 · Reply
Noname2022
Noname2022 Oct. 23 at 8:57 PM
$CRMD $DVA Why promote, DVA contract?!
1 · Reply
Noname2022
Noname2022 Oct. 23 at 8:40 PM
$CRMD $DVA DVA: Deadly Vascular Access or DefenCath Value Added
0 · Reply
RyGuy_79
RyGuy_79 Oct. 23 at 3:14 PM
$CRMD $DVA uses dog water in their catheter locks.
0 · Reply
Noname2022
Noname2022 Oct. 22 at 2:46 PM
$CRMD $DVA $FMS While every other provider protects patients, DaVita chooses to ignore DefenCath, the therapy proven to prevent deadly infections and costly hospitalizations. This isn’t caution or strategy, it’s negligence dressed as cost control. The market sees it, regulators see it, and patients feel it. When the fallout hits, it won’t be measured in dollars, it will be measured in lives.
5 · Reply
SuperGreenToday
SuperGreenToday Oct. 21 at 11:26 PM
$DVA Share Price: $128.40 Contract Selected: Mar 20, 2026 $130 Calls Buy Zone: $9.43 – $11.65 Target Zone: $17.50 – $21.39 Potential Upside: 75% ROI Time to Expiration: 149 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
WARRENBUFFETSIGNAL
WARRENBUFFETSIGNAL Oct. 20 at 8:58 PM
0 · Reply
SweStonk
SweStonk Oct. 20 at 7:41 PM
$CRMD Great day today! $10,99 entry start to feel good after I sold on the runup with a 240% gain 🤑 Hope we start kicking our ATH soon. Sector seems healthy and getting attention which might give us some extra push this time. I hope we hit $22-$24 until next big pullback and then climb our way to $30 🤞 Defencath once again carry us through the crap. Time for $DVA to step up and provide the best care for their patients which is defencath.
0 · Reply
Noname2022
Noname2022 Oct. 18 at 6:05 PM
3 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 17 at 2:42 PM
Enter: $DVA NOV 21 2025 $130 CALLS Buy in Price: $5.54 - $6.30 Take Profit: $13.19 Stop Bleeding: $4.88 ROI Potential: 138% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
Noname2022
Noname2022 Oct. 14 at 8:32 PM
3 · Reply
Noname2022
Noname2022 Oct. 14 at 7:42 AM
$CRMD $DVA DaVita 3Q call on Oct 29 — same script, different quarter. Talking about ‘patient outcomes’ while ignoring the one product that actually improves them.
2 · Reply
SuperGreenToday
SuperGreenToday Oct. 13 at 1:40 PM
$DVA Share Price: $123.67 Contract Selected: Mar 20, 2026 $125 Calls Buy Zone: $9.03 – $11.15 Target Zone: $14.58 – $17.81 Potential Upside: 52% ROI Time to Expiration: 157 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
wolfofwestloop
wolfofwestloop Oct. 13 at 2:53 AM
$AKBA $CRMD $DVA $FMS call and email your Senators and voice your support! It will take 2 minutes or less for each call...
0 · Reply
Noname2022
Noname2022 Oct. 13 at 12:16 AM
1 · Reply
Noname2022
Noname2022 Oct. 12 at 8:59 PM
$CRMD $AKBA $FMS $DVA https://www.fiercehealthcare.com/providers/op-ed-medicare-payment-reform-needed-support-innovation-kidney-care
3 · Reply
Noname2022
Noname2022 Oct. 12 at 5:27 PM
$CRMD $AKBA $FMS $DVA Nov 1 CMS ESRD Rule Updates likely delayed In 2013, after a 16-day government shutdown (Oct 1–17), CMS released the CY 2014 ESRD PPS Final Rule on Dec 2—about 31 days later than the usual Nov 1 deadline, proving shutdowns can delay but not derail Medicare payment rules.
1 · Reply
Noname2022
Noname2022 Oct. 12 at 5:13 PM
$CRMD $AKBA $FMS $DVA House version of S. 2730 – The Kidney Care Access Protection Act expected (after gov’t shutdown of course) https://www.dialysispatients.org/news/support-s-2730-the-kidney-care-access-protection-act/
0 · Reply
Noname2022
Noname2022 Oct. 10 at 6:47 PM
$CRMD $AKBA $FMS $DVA RPA’s bringing nephrology to D.C. right before the CMS rule drops timing doesn’t get more strategic than that.
2 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 9 at 11:24 PM
Keep a close watch on CMCT! $WING $PCAR $DVA $DB
0 · Reply
Jonisonfire
Jonisonfire Oct. 9 at 9:40 PM
$DVA ✅ healthy FCF ✅ good P/E ✅ nice EPS ✅ necessary product/service Oh look, ANOTHER beaten and hidden healthcare gem! Took an initial position.
0 · Reply